United Therapeutics
UTHR
$272.04
Share price
-0.24%
Change (1 day)
26.88%
Change (1 year)
Categories
United Therapeutics (UTHR) - P/B ratio
P/B ratio as of May 2024 : 2.27
According to United Therapeutics's latest financial reports the company has a price-to-book ratio of 2.27.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
United Therapeutics - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.73 | -34.66% |
| 2022-12-31 | 2.64 | 7.49% |
| 2021-12-31 | 2.46 | 23.72% |
| 2020-12-31 | 1.99 | 42.91% |
| 2019-12-31 | 1.39 | -17.77% |
| 2018-12-31 | 1.69 | -43.91% |
| 2017-12-31 | 3.01 | -7.74% |
| 2016-12-31 | 3.27 | -27.08% |
| 2015-12-31 | 4.48 | -7.05% |
| 2014-12-31 | 4.82 | 10.33% |
| 2013-12-31 | 4.37 | 78.48% |
| 2012-12-31 | 2.45 | -14.81% |
| 2011-12-31 | 2.87 | -30.21% |
| 2010-12-31 | 4.12 | -5.83% |
| 2009-12-31 | 4.37 | 67.09% |
| 2008-12-31 | 2.62 | -64.38% |
| 2007-12-31 | 7.34 | 28.71% |
| 2006-12-31 | 5.71 | -2.6% |
| 2005-12-31 | 5.86 | 10.87% |
| 2004-12-31 | 5.28 | 81.27% |
| 2003-12-31 | 2.92 | 43.21% |
| 2002-12-31 | 2.04 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.83 | -19.30% | 🇺🇸 USA |
 Eli Lilly LLY | 58.0 | 2,458.90% | 🇺🇸 USA |
 Baxter BAX | 2.19 | -3.27% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.67 | 61.92% | 🇺🇸 USA |
 Cardinal Health CAH | -7.25 | -419.93% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.64 | 148.71% | 🇬🇧 UK |
 Cytokinetics
CYTK | -16.4 | -824.52% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 2.35 | 3.86% | 🇮🇱 Israel |